Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pfizer Confirms Paxlovid’s High Efficacy And Reassures On Omicron
89% Relative Risk Reduction Confirmed
Dec 15 2021
•
By
Andrew McConaghie
Pfizer's Paxlovid could have a big impact on COVID-19 hospitalizations and deaths once authorized around the world • Source: Alamy
More from Business
More from Scrip